HIV vaccine stimulates 'rare immune cells' in early human trials

A new vaccine approach to HIV that stimulates a set of rare immune cells showed 97% success at targeting those cells in its first tests in humans.

HIV vaccine stimulates 'rare immune cells' in early human
trials
A new vaccine approach to HIV that stimulates a set of rare immune cells showed 97% success at targeting those cells in its first tests in humans.